Exchange: OTC·Updated 03:59 PM EDT

ADTX Aditxt Inc

$0.0068
$0.001
(17.24%)
Today
Mkt Cap$6.83M
Vol44.2M

About ADTX

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Mountain View, CA.
87

Extremely Bullish Sentiment

How do you feel about ADTX?

Advertisement|Remove ads.